Traditional Chinese Medicines ignore science, pose safety concerns, says report
The presence of toxins in Traditional Chinese Medicines (TCM), their questionable clinical trials and lack of scientific evidence about their efficacy are raising many eyebrows.
The detailed results of the trials of TCM are also not being published in public and the presence of toxins is not indicated on the packaging of TCM products due to lack of guidelines and required regulations, according to Inside Over.
Arthur Grollman, a cancer researcher at Stony Brook University in New York, has published work showing how Aristolochic acid, an ingredient in many TCM remedies, can cause kidney failure and cancer.
Furthermore, according to a research titled “Safety Concerns of Traditional Chinese Medicine Injections Used in Chinese”, TCM injections pose serious risks to the pediatric population.
There are cases of adverse drug reactions (ADRs), especially in children that have pushed TCM into the bracket of pseudoscience. This raises concern and before any further use of these medicines, they need rigorous and unbiased research and clinical trials, reported Inside Over.
ADRs in children have been reported in most of the places where TCM is practised, within China and other countries like Nigeria, Tanzania and South Africa.
During the tenure of Margaret Chan, who served as the DG of the WHO from 2006 to 2017, China was able to include TCM in the crucial International Classification of Diseases, ICD-11, for the first time.
However, this inclusion was criticized by the global scientific community. Such a promotion by WHO, ignoring science does not leave space for unbiased and rational decision making while dealing with TCMs.
Original article by admin, if reproduced, please cite the source as: https://www.tcmha.com/tcmnews/traditional-chinese-medicines-ignore-science-pose-safety-concerns-says-report.html
相关推荐
-
Chinese traditional medicine company’s shares surge on Covid outbreak
The stake held by the founding family of one of China’s largest traditional medicine groups has rocketed in value to $4.5bn after the latest Covid-19 outbreaks in the country triggered a renewed surge of interest in its coronavirus treatment. Although the US has explicitly warned against the company’s medicine, shares in billionaire Wu Yiling’s pharmaceutical company Shijiazhuang Yiling Pharmaceutical have jumped more than 60 per cent since the end of December. The latest rally came on top of the stock’s 160 per cent gain in early 2020 after Beijing’s endorsement…
-
Interview: Behind Olympic golds, traditional Chinese medicine plays a role
As Gu Ailing won a historical gold in the women’s Freeski Big Air at the Beijing 2022 Winter Olympic Games, a doctor of the Chinese team revealed the role that Traditional Chinese Medicine (TCM) plays in treating China’s Olympians. Zhu Jiangwei, a physician at the Sichuan Province Orthopedic Hospital, worked for China’s national freeski big air and snowboard slopestyle team between October 2021 and January this year. Along with the team, Zhu traveled to Austria, Switzerland, the United States and other countries, providing medical care to members of the team,…
-
China Wants Traditional Medicine to Quell Its Pneumonia Wave
China’s health-care practices are once again under the spotlight amid a surge in respiratory illnesses, particularly a common bacteria known as mycoplasma pneumoniae, that’s hitting kids hard. Hospital waiting rooms have been overwhelmed with anxious parents who have had to wait hours to see a doctor.
-
Demand soars for Chinese medicine to treat COVID-19 despite Australian ban
It’s the Chinese medicine often compared to paracetamol. Lianhua Qingwen has long been used in mainland China to treat common colds and flu-like symptoms. The traditional Chinese medicine is also given to children, albeit in smaller doses. Since the start of the pandemic, Chinese authorities and scientists have been saying it is even effective at easing symptoms of Covid-19. It’s prompted some members of Australia’s Chinese community to stock-up on the medication available in China over-the-counter and with a prescription. “Lianhua Qingwen is very effective for symptoms such as the…
-
Does gua sha really work? The health benefits of traditional medicine’s ‘best kept secret’
From a traditional Chinese medicine standpoint, it improves stagnation within the body or expels influences that can cause the body to feel still, sore, achy or painful, Minichiello said.
-
Traditional Chinese Medicine indispensable for COVID treatment
He said the World Health Organization has affirmed the effectiveness and safety of traditional Chinese medicine in the treatment of COVID-19 at an expert assessment meeting.
-
Shanghai launches digital TCM innovation center to benefit patients across the world with quality TCM resources
Shanghai has launched a digital traditional Chinese medicine (TCM) innovation center, vowing to benefit patients from across the world with quality TCM treatment resources. The project led by Shanghai University of Traditional Chinese Medicine consists of three parts: the big data center, the internet medical center and the exhibition center of TCM. Based on the health record database of the Shanghai Municipal Health Commission combined with patients’ data from the university and its affiliated hospitals, the big data center will integrate scientific research, medicine research and development, and the inheritance…
-
China to improve traditional Chinese medicine workforce
By 2025, all urban community health centers and rural township health clinics ought to have their own TCM division and personnel, so that residents can enjoy convenient access to TCM services, noted the document.
-
Pakistan says trial of Chinese traditional medicine for COVID-19 successful
KARACHI, Pakistan, Jan 17 (Reuters) – Pakistani health authorities on Monday announced the completion of a successful clinical trial of Chinese traditional herbal medicine for treating COVID-19, as the South Asian nation enters a fifth wave of the pandemic driven by the Omicron variant. The Chinese medicine, Jinhua Qinggan Granules (JHQG) manufactured by Juxiechang (Beijing) pharmaceutical Co Ltd, is already being used in treatment of COVID-19 patients in China. “Since it was tried on patients with different variants of COVID-19, we expect it to be effective on Omicron as on…
-
Hong Kong uses AI to bring Chinese traditional medicine to the US
Researchers from the Center of Chinese Herbal Medicine Drug Development Limited plan to use AI to bring traditional Chinese to the United States. CHM will produce TCM tablets and use artificial intelligence to recommend the right ones to patients.
Comments(1)
Does your blog have a contact page? I’m having problems locating it but, I’d like to shoot you an e-mail. I’ve got some ideas for your blog you might be interested in hearing. Either way, great site and I look forward to seeing it expand over time.